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Abstract
Purpose To compare long-term functional and radiolog-
ical outcome following microfracture technique (MF)
versus osteochondral autologous transplantation (OAT)
mosaicplasty for treating focal chondral lesions of the knee.
Methods Twenty-five patients (mean age 32.3 years, SD
7.7) with a full-thickness (International Cartilage Repair
Society grade 3 or 4) chondral lesion of the articulating
surface of the femur were randomized to either MF
(n = 11) or OAT mosaicplasty (n = 14). At a median
follow-up of 9.8 years (range 4.9–11.4), the patients were
evaluated using Lysholm score (n = 25), Knee Injury and
Osteoarthritis Outcome Score (KOOS, n = 25), isokinetic
quadriceps measurement and hamstring strength measure-
ment (n = 22) and standing radiographs (n = 23).
Results There were no significant differences in Lysholm
score, KOOS, isokinetic muscle strength or radiographic
osteoarthritis between MF-treated patients and OAT mo-
saicplasty-treated patients at follow-up. Mean Lysholm
score at follow-up was 69.7 [95 % confidence interval (CI),
55.1–84.4] for the MF group and 62.6 (95 % CI,
52.6–72.6) for the OAT mosaicplasty group.
Conclusion At long-term follow-up, there were no sig-
nificant differences between patients treated with MF and
patients treated with OAT mosaicplasty in patient-reported
outcomes, muscle strength or radiological outcome.
Level of evidence Therapeutic study, Level II.
Keywords Chondral lesion  Microfracture 
Mosaicplasty  Long-term follow-up  Lysholm  KOOS
Introduction
Chondral or osteochondral lesions of the knee eligible for
cartilage repair surgery are diagnosed in 5–10 % of all
knees subjected to knee arthroscopy [1, 20] and may con-
tribute to disability and premature osteoarthritis (OA) [29].
Furthermore, focal chondral lesions of the knee have been
shown to impair quality of life similar to patients scheduled
for knee replacement, even though the chondral lesion
patients are 30 years younger [18].
Various cartilage repair techniques have been devel-
oped. Resurfacing techniques include abrasion arthroplasty
[24], Pridie drilling [36] and microfracture technique (MF)
[3, 43]. MF procedures stimulate and recruit mesenchymal
cells from the subchondral bone marrow and subsequently
form a fibrin clot that eventually turns into a predominantly
fibrocartilaginous regenerate with inferior biomechanical
characteristics compared to native hyaline articular
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cartilage [11]. Despite fibrocartilage formation, several
short- to mid-term follow-up studies following MF treat-
ment of chondral lesions report significant pain relief and
improvement in knee function [32, 33, 43].
Grafting and transplantation procedures, like autologous
chondrocyte implantation (ACI) [6] and osteochondral
autologous transplantation (OAT) mosaicplasty [16] gained
popularity after introduction in the 1990s. The OAT mo-
saicplasty technique involves open or arthroscopic trans-
plantation of multiple cylindrical osteochondral grafts from
the relatively less weight-bearing periphery of the articular
surface to the cartilage defect, thus providing a hyaline-
cartilage-covered resurfacing [2, 22]. Case series and
comparative trials have reported 83–92 % good to excel-
lent short- to mid-term results following OAT mosaicplasty
[8, 13, 15]. Even though MF and OAT mosaicplasty have
proven to be effective in short- to mid-term follow-up
studies, knowledge regarding long-term outcome remains
uncertain [4, 8, 14, 32, 41, 42]. To our knowledge, there is
only one prospective randomized study comparing the
long-term outcomes following MF and OAT mosaicplasty
[12]. Due to the limited information on the long-term
outcome after these two common cartilage repair tech-
niques, patient information and decision-making regarding
treatment options is challenging for the orthopaedic
surgeon.
In the present prospective randomized study, the pur-
pose was to compare long-term functional and radiological
outcome following MF and OAT mosaicplasty for full-
thickness chondral lesions of the knee. The null hypothesis
was that there is no difference in patient-reported outcomes
or radiographic OA between MF-treated patients and OAT
mosaicplasty-treated patients at long-term follow-up.
Materials and methods
Twenty-five patients [mean age 32.3 years, standard devi-
ation (SD) 7.7] were enroled in the study between
November 2000 and June 2006. Three orthopaedic carti-
lage repair centres participated in the study, and experi-
enced knee surgeons performed both the selection of the
patients and the surgical procedure. Informed consent was
obtained from all patients.
Inclusion criteria were an arthroscopically verified
chondral or osteochondral lesion of International Cartilage
Repair Society (ICRS) grade 3 or 4 [7] located on the
femoral condyle or trochlea, with an area between 2 and
6 cm2 and depth\10 mm. Additionally, the patients had to
be 18–50 years of age with Lysholm score\80 and Tegner
score \6.
Exclusion criteria were radiographic osteoarthritis (OA),
major malalignment, major ligament injury or instability,
extension deficit [3, flexion deficit [5 and chondral
lesion(s) of ICRS grade 3 or 4 on the tibial plateau or
patella. Patients were also excluded if they had contralat-
eral impaired knee function that might influence the ability
to follow the rehabilitation protocol.
Randomization between MF and OAT mosaicplasty was
performed in the operating room, following arthroscopic
debridement. Patients were randomized by a restricted
shuffled approach [39] in blocks of 10, allocation ratio 1:1,
using sequentially numbered sealed envelopes to assign
treatment. The block randomization approach used ensured
that all centres/surgeons performed both procedures and
also ensured randomization to surgeon. Twenty-five
patients were included, and in accordance with randomi-
zation, 14 patients were treated with OAT mosaicplasty
and 11 patients with MF. Group characteristics at inclusion
are shown in Table 1.
A total of 19 patients were excluded from the study. In
most cases, this was due to findings during the arthroscopic
assessment, e.g. size or localization of the chondral lesion
not in accordance with the inclusion criteria or additional
ICRS grade 3 or 4 chondral lesions of the tibia or patella.
Two patients declined surgery due to pregnancy, and two
Table 1 Characteristics of the study groups at inclusion
MF
(n = 11)
OAT
Mosaicplasty
(n = 14)
Age, yearsa (n = 25) 31.7 (8.0) 32.7 (7.8)
Duration of symptoms, mosa (n = 24) 111.0 (77.3) 75.8 (73.5)
Gender, n (%)
Females 5 (45) 6 (43)
Males 6 (55) 8 (57)
Right/left 7/4 8/6
Lesion localization (n = 25)
Trochlea 0 2
Medial femoral condyle 10 10
Lateral femoral condyle 1 2
Lesion sizeb (n = 25) 2.6 (2.0–5.2) 3.0 (2.0–6.0)
Injury mechanism (n = 25)
Gradual onset 0 4
Trauma/acute onset 5 6
Osteochondritis dissecans 6 4
ICRS classification (grade 3/4) 4/7 8/6
Previous cartilage surgeryc 3 1
Tegner activity level scoreb (n = 23) 3 (0–4) 2.5 (0–4)
ICRS International Cartilage Repair Society
a Mean and (standard deviation)
b median and (range)
c Resurfacing and/or grafting and/or transplantation
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patients withdrew their consent at the time of surgery as
they insisted on being treated with one of the surgical
techniques.
Treatment
Microfracture technique
The procedure was arthroscopic and the principles of the
technique introduced by Steadman et al. [43] were used.
Debridement of all damaged and unstable cartilage was
performed, as to obtain stable and healthy cartilage edges.
An arthroscopic awl (Linvatec) was then used to perform
multiple holes (‘‘microfractures’’) about 3–4 mm apart.
The depth of the holes was considered appropriate when
‘‘fat-pearls’’ emerged from the subchondral bone.
OAT mosaicplasty
Following application of a tourniquet, the OAT mosaicpl-
asty was performed through a medial parapatellar arthrot-
omy or a mini-invasive arthrotomy, depending on the
lesion size and localization. Debridement was done similar
to that described for MF. The OAT mosaicplasty procedure
was performed as described by Hangody et al. [16] by
obtaining small cylindrical osteochondral grafts (3.5, 4.5 or
6.6 mm in diameter) from the minimal weight-bearing
periphery of the femoral condyles and transplanting them
‘‘press-fit’’ to recipient tunnels in the prepared lesion site
(Acufex, Smith&Nephew). At the end of the procedure,
the knee was moved through a full range of motion to
check the stability of the osteochondral plugs.
For both techniques, one dose of prophylactic antibiotics
was administrated intravenous in advance of the procedure,
followed by two dosages postoperatively. Intra-articular
Bupivacaine (Marcain) was installed at the end of the
procedure.
Postoperative care
All patients were hospitalized for a minimum of 5 days.
Continuous passive motion (Kinetec) 3–4 h 9 2/day was
started the first postoperative day and continued for four
days. Cold therapy and compression (Aircast Knee Cryo/
Cuff) were applied the two first days postoperatively to
reduce swelling and pain.
Rehabilitation
The rehabilitation programme was similar for both groups.
The programme used was based on the principles and
recommendations of Hangody and Steadman [17, 43]. A
maximum load of 15–20 kg weight bearing was allowed
the initial 6 weeks postoperatively, following gradually
discontinuing of the crutches up to 8 weeks. From 8 weeks,
progression to full weight bearing was encouraged. Phys-
iotherapist-guided rehabilitation was initialized immedi-
ately postoperatively and was continued for a minimum of
6 months. The rehabilitation programme included exer-
cises aiming to restore full range of motion and proprio-
ceptive neuromuscular control as soon as possible,
progressing to dynamic strength exercises from 6 weeks
postoperatively. Patients were generally allowed return to
full activity after 6 months. However, participation in
competitive contact sports or other activities that may
expose the knee to pivoting forces was discouraged until
12 months postoperatively.
Outcome measures
All outcome measures were obtained both at baseline and
follow-up, except for isokinetic muscle strength measure-
ments, which were performed only at follow-up. In addi-
tion to the outcome measures, all patients were also
questioned about any additional surgical procedures to the
knee during the follow-up period.
Lysholm score
The primary outcome measure was the Lysholm score [44],
which is an 8-item (limp, support, locking, instability, pain,
swelling, stair climbing and squatting) questionnaire. The
total score is the sum of each response to the 8 items, of a
possible score of 100 (100 = no symptoms or disability)
The Lysholm score is validated for patients with cartilage
injuries [26], and age and gender-specific population-based
reference data have been established [5]. At follow-up, the
Lysholm questionnaire was completed by the patients prior
to the examination [21].
The Knee Injury and Osteoarthritis Outcome Score
(KOOS)
The KOOS is a self-reported assessment tool consisting of
42 questions distributed between 5 separately scored sub-
scales: pain, other symptoms, activities of daily living
(ADL), function in sport and recreation (Sport/Rec) and
knee-related quality of life (QoL). Each subscale score is
converted to a 0 (worst)–100 (best) scale. The KOOS is
considered as a valid, reliable and responsive questionnaire
for patients with chondral lesions of the knee [10, 38]. Age
and gender-specific population-based reference data of the
KOOS have been established [35]. A difference or change
of 10 points or more in either of the subscales is considered
Knee Surg Sports Traumatol Arthrosc (2014) 22:1207–1215 1209
123
as clinically relevant [10, 37]. At follow-up, the KOOS
questionnaire was completed by the patients prior to the
examination.
Isokinetic muscle strength
Isokinetic quadriceps and hamstring muscle strength tests
were performed at follow-up. It has previously been shown
that muscular strength deficits in various knee disorders are
associated with a poorer outcome, and two recently published
studies found highly significant side-to-side differences in
knee-related muscle strength in ACI-treated patients [27, 30].
In addition, since this is a comparative study between an
arthroscopic and an open procedure, muscle strength
assessments were considered relevant. Muscle strength was
measured using a Biodex 6000 dynamometer (Biodex Med-
ical System Inc., Shirley, New York). This device gives
reliable and valid measurements of dynamic muscle function
on variables related to torque, power and endurance [9].
Before testing, the patients did 10-min warm-up on a sta-
tionary bike. The test protocol consisted of five repetitions at
an angular velocity of 60/s in a concentric mode. Two
physiotherapists, both blinded to the treatment, performed the
measurements. Comparison was made between involved and
uninvolved knee. The parameter used for analysis was peak
torque/highest muscular force output (Nm) expressed as
percentage deficit compared to the uninjured leg.
Radiographs
Radiographs were performed in the AP-plane with the
patients standing with semi-flexed knees. Evaluation and
grading of anonymized radiographs were done according to
the original Kellgren and Lawrence criteria [23] of knee
OA (0 normal to 4 severe). The grading was done by three
of the authors (SU, AA˚ and SL) by consensus agreement.
The study was approved by the Regional Ethical Com-
mittee of South-Eastern Norway, University of Oslo, ID
155-00066.
Statistical analysis
The sample size required to detect a difference in Lysholm
score of 15 between groups was estimated by using the
Altman nomogram. In addition to the predetermined power
(0.80) and level of significance (0.05), the estimation is
based on the calculation of the standardized difference, i.e.
the difference in Lysholm score to be detected divided by
the expected SD. Based on previous studies [40], the SD
was expected to be 17, giving a standardized difference of
15/17 = 0.88. Using these figures, the Altman’s nomogram
revealed that 20 patients in each treatment group would be
sufficient.
SPSS software version 20 (Chicago, IL, USA, 2006) was
used for statistical analysis. Lysholm, KOOS and isokinetic
muscle strength deficits compared to uninjured leg at fol-
low-up were compared between the treatment groups using
Mann–Whitney U test. Changes in Lysholm and KOOS
from baseline to follow-up were compared using Wilcoxon
signed rank test. Changes in radiographic appearance
according to Kellgren–Lawrence classification were com-
pared between the two groups using Fishers exact test.
Level of significance was defined as p B 0.05.
Results
At a median follow-up of 9.8 years (range 4.9–11.4 years),
all patients (25/25) reported Lysholm score and KOOS.
One patient had moved abroad, and another was not
available for examination in the outpatient clinic. However,
these patients were contacted by postal mail and telephone,
and returned their questionnaires.
Mean Lysholm score for patients treated with MF and
OAT mosaicplasty at baseline and at follow-up are shown
in Fig. 1. No significant differences in mean Lysholm score
were detected between MF-treated patients and OAT mo-
saicplasty-treated patients at follow-up (n.s.), or in mean
change from baseline to follow-up (Table 2). MF-treated
patients scored 48.2 (95 % CI, 38.2–58.2) preoperatively
0
10
20
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40
50
60
70
80
90
100
preop follow-up
MF OAT Mosaicplasty Reference Lysholm score*
Fig. 1 Mean Lysholm score for patients treated with MF (n = 11)
and OAT mosaicplasty (n = 14) at preoperative and follow-up.
*Lysholm score acquired from a normal, healthy population as a
standard point of reference for the injured or postsurgical knee, as
described by Briggs, K.K. et al., Am J Sports Med, 2009
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and OAT mosaicplasty-treated patients 49.2 (95 % CI,
43.0–55.4). The mean Lysholm score at follow-up in the
MF group was 69.7 (95 % CI, 55.1–84.4) compared to 62.6
(95 % CI, 52.6–72.6) in the OAT mosaicplasty group. The
increase in Lysholm score from baseline to follow-up was
significant for both groups (Table 2).
The KOOS profiles with mean scores at inclusion and at
follow-up for the MF group and the OAT mosaicplasty
group are shown in Fig. 2. There were no significant dif-
ferences between the two groups in any of the KOOS
subscales at follow-up or in the changes from baseline to
follow-up (Table 2). The increase in KOOS from baseline
to follow-up within the treatment groups was significant for
all subscales except for ADL in the microfracture group,
and pain, symptoms and ADL in the OAT mosaicplasty
group (Table 2).
Isokinetic muscle strength measurements (n = 22) of
the knee extensors and flexors at follow-up are shown in
Table 3. There were no significant differences between the
MF group and OAT mosaicplasty group in mean strength
deficit of the affected knee. A significant mean extension
strength deficit of the affected knee, compared to the
unaffected, was detected in the OAT mosaicplasty group.
Twenty-three patients performed radiographic exami-
nation at follow-up. No patient had radiological signs of
osteoarthritis of any knee at inclusion. Osteoarthritis was
defined as Kellgren–Lawrence C2 and was detected in the
affected knee in 5 of 11 patients in the MF group and 2 of
12 in the OAT mosaicplasty group at follow-up
(p = 0.193). Osteoarthritis in the unaffected leg was
detected in 3 of 11 knees in the MF group and in 1 of 12
knees in the OAT mosaicplasty group.
Mean body mass index (BMI) at follow-up was 28.2
(SD 4.2) for patients treated with MF and 27.9 (SD 3.8) in
the OAT mosaicplasty group.
Reoperations and additional surgical procedures during
follow-up are outlined in Table 4.
Discussion
The main finding of the present study is that the long-term
outcomes following MF and OAT mosaicplasty for treating
focal chondral lesions of the knee are comparable. The
evidence in this material is not sufficient to reject the study
hypothesis that there is no difference between the two
alternative treatments. However, the small number of
included patients makes any firm conclusions regarding the
hypothesis testing difficult. Due to less eligible patients for
Table 2 Mean change in Lysholm score and Knee Injury and Osteoarthritis Outcome Score from preoperative to follow-up, and mean difference
in change over time between the MF group and OAT mosaicplasty group
MF OAT Mosaicplasty MF vs OAT mosaicplasty p value
Change over time Change over time Change over time
Mean (95 % CI) Mean (95 % CI) Mean difference (95 % CI)
Lysholm 21.6 (3.7–39.4) 13.4 (0.9–25.8) 8.2 (-11.7 to 28.1) n.s
KOOS Pain 20.6 (2.8–38.3) 11.8 (-2.8 to 26.4) 8.8 (-12.7 to 30.3) n.s
KOOS Symptoms 17.4 (2.6–32.2) 8.5 (-3.5 to 20.6) 8.9 (-8.9 to 26.7) n.s
KOOS ADL 13.0 (-3.8 to 29.8) 7.5 (-4.3 to 19.3) 5.5 (-13.4 to 24.4) n.s
KOOS Sport/Rec 32.4 (13.3–51.6) 41.3 (23.7–58.9) -8.9 (-33.4 to 15.7) n.s
KOOS QoL 34.6 (15.1–54.0) 25.0 (10.6–39.3) 9.6 (-12.7 to 31.9) n.s
Change over time = follow-up minus preoperative
Mean difference = mean change over time in MF group minus mean change over time in OAT mosaicplasty group
CI confidence interval, p level of significance, ADL activities in daily living, Sport/Rec function in sport and recreation, QoL knee-related quality
of life
Fig. 2 Knee Injury and Osteoarthritis Outcome Score (KOOS) at
inclusion and follow-up for the MF group and the OAT mosaicplasty
group. *Reference population as described by Paradowski et al. [35]
BMC Musculoskelet Disord
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the study than expected, the duration of the inclusion
period was extended up to 5 years. Still only 25 patients
were enroled in the study. However, no patients were lost
to follow-up.
Reoperations occurred in 6/11 patients (54 %) in the MF
group and in 5/14 patients (36 %) in the OAT mosaicplasty
group. Even though non-significant, all knees that under-
went a second cartilage repair procedure (n = 3) or a total
knee arthroplasty (n = 1) belonged to the MF group. It
should also be noted that a significant reduction in exten-
sion force of the affected leg, compared to the unaffected,
was found in the OAT mosaicplasty group, even though a
mini-invasive arthrotomy was used when possible.
Both treatment groups reported significant improvement
in Lysholm score and in several of the KOOS subscales
from baseline to follow-up at 9.8 years. However, the mean
Lysholm score and KOOS at follow-up were considerably
lower than in the reference population [5, 35], which
indicates that the long-term patient-reported outcomes are
modest for both treatments. In addition, the wide confi-
dence intervals indicate diversity among the patients,
which however, is not an uncommon finding in long-term
follow-up studies on cartilage repair [4, 45]. The unpre-
dictability of these two cartilage repair methods has been
found in standardized controlled animal studies as well
[19].
To our knowledge, there are only two other clinical
studies comparing MF and OAT mosaicplasty [12, 28]. In
the only randomized trial, the OAT mosaicplasty-treated
patients scored significantly higher on the ICRS outcome
scores and Tegner scores compared to the MF-treated
patients at a mean follow-up of 10.4 years [12]. Further-
more, the failure rate and the decrease in sports activity
were significantly higher for the MF group. Although our
study did not demonstrate any significant difference
regarding reoperations, the trend was that reoperations
occur more often in the MF group. However, comparison
between the studies is difficult due to differences in studyT
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Table 4 Reoperations and additional surgical procedures during
follow-up
MF
(n = 11)
OAT mosaicplasty
(n = 14)
Procedures 6 5
ACI 2
OAT mosaicplasty 1
Open wedge osteotomy 1
Removal of loose body 1
Diagnostic arthroscopy/debridement 1 4
Scheduled to TKA 1
ACI autologous chondrocyte implantation, TKA total knee
arthroplasty
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populations, surgical techniques and the use of other out-
come measures. Gudas et al. included competitive or well-
trained athletes, whereas the present study did not exclude
non-athletes. Several studies indicate that both OAT mo-
saicplasty and MF provide favourable outcome in small
lesions [4, 8, 25, 31, 34]. The fact that relatively small-
sized lesions \2 cm2 were included and that lesions
[4 cm2 were excluded in the Gudas study might in part
explain the apparently better results at follow-up in that
study compared to the present study. Another difference
between these two studies is that in the Gudas study, all
OAT mosaicplasty patients were treated arthroscopically,
whereas in the current study an arthrotomy was performed
in all mosaicplasty procedures.
In a recent retrospective, comparative study, Krych et al.
[28] showed that both MF and OAT mosaicplasty-treated
patients reported significant improvements in knee function
and activity level at 5-year follow-up. No significant dif-
ferences were detected between the two groups regarding
knee function, but the mosaicplasty group maintained a
superior level of activity compared to those treated with
MF. The main findings of that study are in line with those
of the present study, but the validity of the conclusions in
the study of Krych et al. is limited by the study design,
since it allows for selection bias. The unevenly distributed
number of patients with previous cartilage surgery, and
osteochondritis dissecans, should also be accounted for in
the study by Krych et al.
There are few long-term follow-up studies following
MF for treating chondral lesions of the knee. In a sys-
tematic review by Mithoefer et al. [32] only 5 studies
reported a follow-up of 5 years or more, and the reports on
the durability of the initial functional improvement were
conflicting. The present study shows that functional
improvement after MF is to be expected as long as
9.8 years after surgery.
The long-term outcome following OAT mosaicplasty in
the present study supports the findings from other studies
on OAT mosaicplasty, indicating acceptable long-term
clinical outcome given the appropriate indication for sur-
gery, a limitation being the defect size [12, 14, 41].
The main limitation of this study is the small number of
included patients, which may lead to a false affirmation of
the null hypothesis (type II error). On the other hand, the
follow-up of 100 % for the main outcome (Lysholm score),
and the high follow-up (88–100 %) and uniformity of
comparable results between the two groups in the addi-
tional broad spectrum of outcome measures, strengthens
the validity of the conclusion. Other limitations of the
study are lack of a mid-term evaluation and the incom-
pleteness of the preoperative strength measurements.
In the light of the limited information in current litera-
ture on the topic of long-term comparison between MF and
OAT mosaicplasty, there is a need for further RCTs and a
future cartilage repair registry in order to monitor and
assess the cartilage repair procedures in use. The results
from the current study might help the orthopaedic surgeon
in the preoperative decision-making and in informing the
patient what to expect concerning long-term outcome fol-
lowing these two cartilage repair techniques.
Conclusion
At long-term follow-up, there were no significant differ-
ences between patients treated with MF and patients treated
with OAT mosaicplasty in patient-reported outcomes,
muscle strength or radiological outcome. Both MF-treated
as well as OAT mosaicplasty-treated patients reported
improved knee function compared to the preoperative
level. However, compared to a reference population, infe-
rior patient-reported knee function was found in both
treatment groups at follow-up.
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